Keyphrases
Clinical Trials
71%
Core Outcome Set
48%
Risk-benefit
46%
Patient Benefit
45%
Patient Outcomes
45%
Drug Development
44%
Risk Outcomes
43%
Patient Risk
43%
Reporting Guidelines
38%
Clinical Trial Registry
35%
Randomized Controlled Trial
30%
Sectional Analysis
23%
Web-based Survey
15%
Trialists
14%
Frequently Asked Questions
13%
Adverse Events
13%
Google Search
12%
Objective Response Rate
10%
Meta-epidemiological Study
10%
Clinical Perspective
10%
FDA-approved Drugs
10%
Trial Registration
10%
Overall Survival
9%
Google
9%
Scopus
8%
Cochrane
7%
Patient-reported Outcomes
7%
Ramucirumab
7%
Instructions to Authors
7%
PubMed
7%
Embase
7%
Medical Practice
7%
Approved Indication
7%
Trial Characteristics
6%
Online Information
5%
PRISMA
5%
CiteScore
5%
Descriptive Statistics
5%
Health Research
5%
Median Progression-free Survival
5%
Progression-free Survival
5%
Chronic Kidney Disease
5%
Cancer Clinical Trials
5%
Inflammatory Bowel Disease
5%
Regorafenib
5%
Olaparib
5%
Bunion
5%
Hallux Valgus
5%
Peptic Ulcer Disease
5%
Lenvatinib
5%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Drug Development
44%
Randomized Controlled Trial
20%
Adverse Event
19%
Malignant Neoplasm
18%
Overall Survival
13%
Progression Free Survival
11%
Cross Sectional Study
11%
Cross-Sectional Study
8%
Ramucirumab
7%
Inflammatory Bowel Disease
5%
Chronic Kidney Failure
5%
Lenvatinib
5%
Afatinib
5%
Regorafenib
5%
Olaparib
5%
Infection
5%
Selinexor
5%
Medicine and Dentistry
Clinical Trial
65%
Cross Sectional Study
33%
Randomized Controlled Trial
22%
Systematic Review
16%
Patient-Reported Outcome
7%
Ramucirumab
7%
Adverse Event
7%
Chronic Kidney Disease
5%
Jejunum Ulcer
5%
Osteoarthritis
5%
Olaparib
5%
Parkinson's Disease
5%
Nephrology
5%
Lung Cancer
5%
Family Practice
5%
Endocrinology
5%
